This article is more than 5 years old. Information may no longer be current.
Best of AWIR Immunology Bootcamp
Click Here to Manage Email Alerts
Immune-mediated inflammatory disease (IMID) is a group of clinically heterogeneous disorders that share common immunopathology. The continued evaluation and refinement of biologic therapies in the treatment of IMID have provided significant benefit to patients suffering from these disorders. However, recognizing the underlying immunopathological mechanisms of IMID is essential for understanding how current and emerging biologics exert their effects. In this CME educational activity, held during the Association of Women in Rheumatology National Conference, experts in the field will review and discuss the immunological pathways that regulate the activity of the immune system in IMID.
Click here to see this Education Lab Activity.
Learning Objectives:
Upon successful completion of this educational activity, participants will be better able to:
- Assess immunological targets of available and emerging immune-based therapies.
- Review the underlying principles of immunity and inflammation as they contribute to the immunopathology of immune-mediated inflammatory diseases (IMIDs) such as rheumatoid arthritis.
- Select treatment for patients with IMID based on the latest clinical evidence, as well as patient characteristics and prognosis.
Overview
Author(s)/Faculty: Grace C. Wright, MD, PhD, FACR; Leonard H. Calabrese, DO; Jeffrey L. Kaine, MD; John R. P. Tesser, MD
Source: Healio Rheumatology Education Lab
Type: Lecture
Articles/Items: 5
Release Date: 10/26/2014
Expiration Date: 10/25/2018
Credit Type: CME
Number of Credits: 1
Cost: Free
Provider: Vindico Medical Education
CME Information
Sponsorship Statement: This continuing medical education activity is provided by Vidico Medical Edutcation.
Support Statement: This activity is supported by educational grants from AbbVie, Inc.; Lilly USA, LLC; and Sanofi Genzyme and Regeneron Pharmaceuticals.
Endorsed by: Immunology and Biologics Educational Collaborative
Target Audience: The intended audience for this activity is rheumatologists, nurse practitioners, physician assistants, and other health care professionals involved in the treatment of patients with rheumatoid arthritis and other immune-mediated inflammatory diseases.